Yinying Ni

Yinying Ni

Auto-generated profile, based on publicly available information

Yinying Ni

Institute of Cerebrovascular Disease, The Affiliated People’s Hospital, Jiangsu University, Zhenjiang, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
TGTao Guo
Tao Guo
YWYuxin Wang
Yuxin Wang
MHMuhammad Abid Hayat
Muhammad Abid Hayat
YSyu si
yu si
YNYining Ni
Yining Ni
JHJiabo Hu
Jiabo Hu


30 December 2024 in Research Square
Verified
Preprint
Open access
PDF file
JZJiangwen Zhang
Jiangwen Zhang
MHMuhammad Abid Hayat
Muhammad Abid Hayat
YSyu si
yu si
TGTao Guo
Tao Guo
YNYinying Ni
Yinying Ni
JHJiabo Hu
Jiabo Hu
Objective Interleukin-37 (IL-37), an anti-inflammatory cytokine within the interleukin-1 (IL-1) family, exhibits immunomodulatory properties. Here we evaluate the effects of IL-37 on microglia in neuroinflammation and its potential mechanisms. Methods C57BL/6 mice were injected intraperitoneally with 1 μg of recombinant human IL-37 protein (rhIL-37), and 24 h later with lipopolysaccharide (LPS) (5 mg/kg) to induce neuroinflammation. After 2-hour pretreatment of BV2 cells with rhIL-37 (100 ng/mL), an in vitro model was established by treating with LPS (100 ng/mL). Mice were assessed for behavioral tests, and neuronal damage was evaluated by Nissl staining and hematoxylin and eosin staining. The expression of Iba1, CD86, CD206, and NF-κB were detected by immunofluorescence staining, and inflammatory mediators and pathway proteins were evaluated by ELISA, qRT-PCR, and Western blot. Results IL-37 significantly ameliorated LPS-induced behavioral deficits and protected mice from inflammatory injury. In vitro experiments suggested that IL-37 modulates polarization of microglia from M1 to M2 phenotype, along with reducing pro-inflammatory cytokine production. Moreover, IL-37 attenuated the production of NF-κB and MyD88. Conclusions IL-37 regulates microglia against neuroinflammatory responses by blocking the MyD88/NF-κB pathway and shows for the first time how IL-37 influences the phenotype of microglia, suggesting a potential therapeutic target for neuroinflammation.